Antibody-drug conjugates for H3K27M-mutant diffuse midline gliomas: Prospects and challenges

Julian S. Rechberger, Erica A Power, Elena Millesi, David J. Daniels

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)553-557
Number of pages5
JournalTherapeutic Delivery
Issue number8
StatePublished - Aug 2021


  • H3K27M
  • antibody-drug conjugate
  • convection-enhanced delivery
  • diffuse intrinsic pontine glioma
  • diffuse midline glioma
  • efficacy
  • half-life
  • targeted therapy
  • theragnostic
  • volume of distribution

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this